A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Pfizer
Pfizer
M.D. Anderson Cancer Center
Shanghai Junshi Bioscience Co., Ltd.
Immodulon Therapeutics Ltd
Eli Lilly and Company
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)